Victory Square Technologies Reports Q1 2024 Financial Results

Victory Square Technologies Inc.
Victory Square Technologies Inc.

In This Article:

  • Topline Revenue for the three-months ended March 31, 2024, was $5,052,069

  • Cash & liquid securities approx. $4,410,203

  • Notable Portfolio Company Highlights: Hydreight, GameOn, XR Immersive, Covalent, FansUnite, Turnium, CoPilot AI, Stardust Solar, Safetest Comércio de Diagnósticos, CloudAdvisors and Insu Therapeutics

  • Victory Square Q&A Investor Webinar with CoPilot AI CEO Jesse Chen.

VANCOUVER, British Columbia, May 31, 2024 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that gives investor access to a portfolio of 25+ innovative companies from around the world in a single stock, announces it has filed its Consolidated Financial Statements for the quarter ended March 31st, 2024 along with its Management Discussion and Analysis (MD&A).

“We are living in the midst of the 4th Industrial Revolution; The Tech Revolution that will undoubtedly change everything as we know it,” said Shafin Diamond Tejani, CEO Victory Square. “Artificial Intelligence, Machine Learning, Web3, Gaming, Virtual and Augmented Reality, the Creator Economy, Digital Health and Climate Tech are all sectors that Victory Square has invested in. We offer investors the chance to invest in the most exciting tech trends all in one place with a uniquely liquid, audited and secure way to gain access to these latest innovative technologies.”

Financial Highlights
The Company’s condensed consolidated interim financial statements comprise the financial statements of the Company and its subsidiaries: Futura Health and Wellness Inc. (“Futura”), Hydreight Technologies Inc. (“HTI”), Victory Square Digital Health Inc. (“VS Digital Health”), Draft Label Technologies Inc. (“Draft Label”), XR Immersive Tech Inc. (“XRI”) and Synthesis VR Inc. (“SVR”), PDL USA Inc. (“PDL USA”), BlockX Capital Corp. (“BlockX Capital”), VS Blockchain Assembly (“VS Blockchain”), Insu Therapeutics Inc. (“Insu”)

Victory Square invests in early-stage technology companies. Increases and decreases in the value of those companies have the greatest impact on the results of operations of the Company from quarter to quarter. It is within the business cycle to see periods of net losses when first investing in a new company, spending up to 48 months incurring expenses and building the business, and then in subsequent periods realizing the gains and revenues from those early investments.

The net loss for the quarter ended March 31, 2024, is primarily due to the fair value write-down on portfolio investments due to the market environment as well as operating losses from consolidated subsidiaries.